［1］Utnes P,Lokke C,Flaegstad T,et al.Clinically relevant biomarker discovery in high-risk recurrent neuroblastoma［J］.Cancer Inform,2019(18):1883388082.
［2］Ye W,Wang J,Li W,et al.Comparative analysis of flow cytometry and cytomorphology for neuroblastoma cell detection in effusion and bone marrow specimens［J］.Fetal Pediatr Pathol,2019,38(1):1-7.
［3］HUANG Shan,LI Huixia,DONG Hui,et al.Clinical characteristics and prognostic factors of 36 children with neuroblastoma［J］.Modern Oncology,2019,27(06):1035-1039.［黄闪,李慧霞,董慧,等.儿童神经母细胞瘤36例临床特点及预后因素分析［J］.现代肿瘤医学,2019,27(06):1035-1039.］
［4］ WEI Shanqiu,MO Wuning.Significance of bone marrow smear examination in the diagnosis of neuroblastoma［J］.Laboratory Medical Journal,2011,26(06):394-397.［韦善求,莫武宁.骨髓涂片检查对神经母细胞瘤诊断的意义［J］.检验医学,2011,26(06):394-397.］
［5］ YANG Shen,CAI Siyu,PENG Xiaoxia,et al.Prediction and monitoring of progression in the treatment of neuroblastoma in middle and high risk children［J］.Chinese Journal of Pediatric Hematology and Oncology,2018,23(02):62-68.［杨深,蔡思雨,彭晓霞,等.中高危儿童神经母细胞瘤治疗过程中发生进展的预测及监测指标［J］.中国小儿血液与肿瘤杂志,2018,23(02):62-68.］
［6］ PENG Xiongwen,SHEN Leyuan,WANG Weida,et al.Judging the bone marrow involvement of patients with neuroblastoma by blood changes ［J］.Journal of Medical Research,2018,47(10):129-134.［彭雄文,沈乐园,王维达,等.通过血象变化判断神经母细胞瘤患者骨髓累及情况［J］.医学研究杂志,2018,47(10):129-134.］
［7］ Barco S,Verly I,Corrias MV,et al.Plasma free metanephrines for diagnosis of neuroblastoma patients［J］.Clin Biochem,2019（66）:57-62.
［8］ ZHOU Zhenling.Diagnostic value of SPECT bone imaging for bone metastasis of malignant tumors［J］.Imaging Research and Medical Applications,2019,3(06):121-122.［周振玲.SPECT骨显像检查恶性肿瘤骨转移的应用诊断价值［J］.影像研究与医学应用,2019,3(06):121-122.］
［9］ LIU Shihong.To explore the diagnostic value of 99Tcm-MDP SPECT bone imaging/CT image fusion for atypical bone metastases［J］.Imaging Research and Medical Applications,2017,1(13):51-52.［刘世宏.探讨99Tcm-MDP SPECT骨显像/CT图像融合对非典型骨转移肿瘤的诊断价值［J］.影像研究与医学应用,2017,1(13):51-52.］
［10］ZHANG Long,YANG Ying,WANG Zhipeng,et al.The CT features of neuroblastoma in children with bone metastases［J］.Chinese Journal of CT and MRI,2018,16(12):136-138.［张龙,杨莹,王志鹏,等.儿童神经母细胞瘤伴骨转移的CT特点［J］.中国CT和MRI杂志,2018,16(12):136-138.］
［11］Liao Ru,Zhai Zijun,Zhu Jia,et al.Relationship between bone marrow remission rate and prognosis after high risk neuroblastoma of bone marrow metastasis［J］.Chinese Journal of Pediatric Hematology and Oncology,2017,22(01):7-13.［廖茹,甄子俊,朱佳,等.骨髓转移的高危神经母细胞瘤治疗后骨髓缓解速度与预后关系［J］.中国小儿血液与肿瘤杂志,2017,22(01):7-13.］
［12］JIAO Guangli,OUYANG Qiaohong,DUAN Zhongxiang,et al.Clinical application of radionuclide whole body bone imaging in the diagnosis of bone metastases in children with neuroblastoma［J］.Chinese Journal of Bone and Joint,2017,6(08):592-595.［焦光丽,欧阳巧洪,段中响,等.核素全身骨显像在诊断儿童神经母细胞瘤骨转移中的临床应用［J］.中国骨与关节杂志,2017,6(08):592-595.］
［13］ZHAO Ruifang,DONG Weiran,LI Yiwei,et al.Value of bone imaging in evaluating bone metastasis of pediatric neuroblastoma and follow-up after treatment［J］.Shanghai Medical Imaging,2012,21(04):262-264.［赵瑞芳,董岿然,李益卫,等.骨显像在评价小儿神经母细胞瘤骨转移及治疗后随访中的价值［J］.上海医学影像,2012,21(04):262-264.］
［14］XUE Feng.Comparison of the value of ECT bone imaging,CT and DR in the diagnosis of bone metastases［J］.Chinese Health Standards Management,2017,8(06):97-99.［薛峰.ECT骨显像、CT和DR在骨转移瘤诊断中的价值研究对比［J］.中国卫生标准管理,2017,8(06):97-99.］
［15］WANG Zhancheng.Clinical and pathological analysis of 13 cases of neuroblastoma bone marrow metastasis［J］.Journal of Modern Medicine and Health Research,2018,2(09):70.［王占成.神经母细胞瘤骨髓转移13例临床病理分析［J］.现代医学与健康研究电子杂志,2018,2(09):70.］
［16］YIN Renbin,CHEN Huishu,CHANG Juan,et al.Histological and morphological features of 373 cases of bone marrow metastasis［J］.Journal of Diagnostic Pathology,2018,25(04):270-274.［殷仁斌,陈辉树,常娟,等.骨髓转移瘤373例组织形态学特点［J］.诊断病理学杂志,2018,25(04):270-274.］